Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Assets (2020 - 2025)

Historic Assets for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $308.5 million.

  • RxSight's Assets fell 62.36% to $308.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $308.5 million, marking a year-over-year decrease of 62.36%. This contributed to the annual value of $318.6 million for FY2024, which is 7450.73% up from last year.
  • RxSight's Assets amounted to $308.5 million in Q3 2025, which was down 62.36% from $309.0 million recorded in Q2 2025.
  • RxSight's Assets' 5-year high stood at $318.6 million during Q4 2024, with a 5-year trough of $94.9 million in Q2 2021.
  • Moreover, its 5-year median value for Assets was $194.0 million (2021), whereas its average is $219.5 million.
  • In the last 5 years, RxSight's Assets soared by 9142.51% in 2021 and then crashed by 2357.46% in 2022.
  • Quarter analysis of 5 years shows RxSight's Assets stood at $192.7 million in 2021, then dropped by 22.08% to $150.2 million in 2022, then increased by 21.57% to $182.5 million in 2023, then soared by 74.51% to $318.6 million in 2024, then fell by 3.15% to $308.5 million in 2025.
  • Its Assets was $308.5 million in Q3 2025, compared to $309.0 million in Q2 2025 and $313.0 million in Q1 2025.